Skip to main content

1 Result(s)

within Tileli Amimeur Remove this filter

and

  1. No Access

    Protocol

    Deep Learning in Therapeutic Antibody Development

    Deep learning applied to is in its adolescence. Low data volumes and biological platform differences make it challenging to develop supervised models that can predict antibody behavior in actual commercial d...

    Jeremy M. Shaver, Joshua Smith, Tileli Amimeur in Artificial Intelligence in Drug Design (2022)